Literature DB >> 30007645

Discovery of a polysaccharide from the fruiting bodies of Lepista sordida as potent inhibitors of indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells via blocking of STAT1-mediated JAK-PKC-δ signaling pathways.

Qiang Luo1, Liang Yan2, Pan Xu1, Chuan Xiong3, Zhirong Yang4, Peng Hu1, Huidong Hu1, Ren Hong5.   

Abstract

The present study examined the role of a polysaccharide (LSP, 25 and 100 μg/ml) from the fruiting bodies of Lepista sordid on the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells, and the possible mechanism of action. IDO expression and kynurenine production from LSP-treated HepG2 cells following IFN-γ stimulation were dramatically inhibited by LSP treatment. In line with this, the medium of HepG2 cells pretreated with LSP improved the survival rate of primary CD4+ and CD8+ T cells as compared with IFN-γ-treated control cells. Moreover, tyrosine 701 and serine 727 phosphorylation of STAT1 were dramatically reduced by LSP pretreatment in IFN-γ-stimulated HepG2 cells. Furthermore phosphorylation of JAK-1 and JAK-2 was also inhibited by LSP. Additionally, two IDO promoters (GAS and ISRE) were inhibited in cells pretreated with LSP prior to IFN-γ exposure. These findings suggest that LSP exerts antitumor effects on HepG2 cells by inhibiting IDO via JAK-PKC-δ-STAT1 signaling pathway.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); IFN-γ; Indoleamine 2,3-dioxygenase (IDO); JAK-PKC-δ-STAT1 signaling pathway; Lepista sordid polysaccharide

Mesh:

Substances:

Year:  2018        PMID: 30007645     DOI: 10.1016/j.carbpol.2018.05.052

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

Review 1.  The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment.

Authors:  Xinting Huang; Feng Zhang; Xiaobo Wang; Ke Liu
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

Review 2.  Kynurenines as a Novel Target for the Treatment of Malignancies.

Authors:  Adrian Mor; Anna Tankiewicz-Kwedlo; Dariusz Pawlak
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.